IP Library Granted Patent US 10,844,014
Granted Patent B2
US 10,844,014 · App. 16/664,464 · Granted Nov 24, 2020

Intermediates for the preparation of remifentanil hydrochloride

Inventors: Pavol Valachovic (Pezinok, SK); Janka Králová (Pezinok, SK); L'ubo{hacek over (s)} Slí{hacek over (z)}ik (Senec, SK); Norbert Varga (Modra, SK)
Assignee: HAMELN PHARMA GMBH
C07D211/98
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,844,014
App. No.
16/664,464
Granted
Nov 24, 2020
Kind
B2
Abstract

A new intermediate for synthesizing 1-substituted-4-[phenyl(propanoyl)amino]piperidine-4-carbonitrile derivatives is laid open. Specifically set out is a method for use of this intermediate in the preparation of remifentanil. The enclosed shorter process offers a greater yield of products with higher purity as compared to methods reported in the prior art.

Claims (12)

1. A compound of formula 20 or a salt thereof:

2. A method for synthesizing Remifentanil (1) or a salt thereof, the method selected from the group consisting of Method A and Method B, wherein Method A comprises reacting the compound of claim 1 or a salt thereof with an acylating agent, optionally in the presence of an acid scavenger, to produce a compound of formula (21), and reacting the compound of formula (21) with methanol under acidic conditions, and Method B comprises hydrolyzing the compound of claim 1 or a salt thereof with an acid, esterifying the hydrolyzed product with an alcohol to produce a compound of formula (12), and reacting the compound of formula (12) with an acylating agent, whereby Remifentanil (1) or a salt thereof is synthesized

3. The method of claim 2 , wherein the compound of formula (20) is first converted to a compound of formula (21)

4. The method of claim 3 , wherein the acylating agent is propionic anhydride or propionyl chloride.

5. The method of claim 4 , wherein the acid scavenger is selected from the group consisting of triethylamine, morpholine, piperidine, and pyridine.

6. A method for preparing a compound of claim 1 , the method comprising reacting a compound of formula (19) with phenylamine in the presence of a cyanide compound to produce a compound of formula (20).

7. The method of claim 6 , wherein the cyanide compound is sodium cyanide.

8. The method of claim 6 , further comprising preparing the compound of formula (19) by alkylating 4-piperidone monohydrate hydrochloride with an appropriate alkylating agent in the presence of a basic catalyst, whereby a compound of formula (19) is prepared.

9. The method of claim 8 , wherein the appropriate alkylating agent is selected from the group consisting of 3-chloropropionitrile, 3-bromopropionitrile, 3-iodopropionitrile, 2-cyanoethyl methanesulfonate, and 2-cyanoethyl 4-methyl benzenesulfonate.

10. The method of claim 9 , wherein the basic catalyst is selected from the group consisting of sodium or potassium carbonate, sodium hydrogen carbonate, sodium or potassium hydroxide, sodium amide, potassium terc-butoxide, and sodium ethoxide.

11. The method of claim 8 , wherein the alkylating is performed in the presence of a solvent, optionally wherein the solvent is selected from the group consisting of acetone, methyl ethyl ketone, isopropanol, acetonitrile, N,N-dimethylacetamide, N,N-dimethylformamide, tetrahydrofuran, and 2-methyl tetrahydrofuran.

12. A method for synthesizing remifentanil hydrochloride, wherein the method is according to the following scheme:

Assignments (2)
CHANGE OF NAME Recorded Oct 14, 2020
From: HAMELN PHARMA PLUS GMBH
To: HAMELN PHARMA GMBH
Reel/Frame 054674/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2019
From: VALACHOVIC, PAVOL; KRÁLOVÁ, JANKA; SLÍ?IK, LUBO?; VARGA, NORBERT
To: HAMELN PHARMA PLUS GMBH
Reel/Frame 050834/0495 →
Priority Claims (1)
EP 18202878 · Oct 26, 2018 · regional
Continuity (1)
Related Publication 20200131127A1 · Apr 30, 2020